Mandate

Vinge advises Barclays Bank PLC in connection with its establishment in Sweden

November 19, 2013

Vinge has advised Barclays Bank PLC in connection with its establishment in Sweden which included, among other things, extensive contacts with the Swedish Financial Supervisory Authority. Barclays Bank PLC is one of the world’s largest financial services providers and engages in personal banking, credit cards, corporate and investment banking, wealth and investment management. Barclays Bank PLC has an extensive international presence in Europe, the Americas, Africa and Asia and, as a result of its establishment in Sweden, Barclays intends to strengthen its presence in the Nordic region and thereby increase its service offering for existing and potential customers. Barclays Bank PLC’s extensive authorisations for its Swedish operations are set forth on the Swedish Financial Supervisory Authority’s website; www.fi.se.

Vinge’s advice pertained to, among other things, authorisation issues relating to financial services, passporting of existing authorisations within the EEA, anti-money laundering, consumer law, tax law and real estate law. The work was undertaken in consultation with Barclay’s corporate counsel teams in London and Frankfurt.

Vinge’s team consisted of responsible partner Fredrik Wilkens together with a team of financial services specialists including Emma Stuart-Beck, Malin Sund, Helena Håkansson and Sabina Börjesson. In addition, Maria Schultzberg and Ulf Nilsson advised on tax law, Fredrik Gustafsson and Åsa Gotthardsson advised on employment law issues and Martin Folke advised on real estate issues.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025